These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27247345)

  • 1. Clindamycin Affects Group A Streptococcus Virulence Factors and Improves Clinical Outcome.
    Andreoni F; Zürcher C; Tarnutzer A; Schilcher K; Neff A; Keller N; Marques Maggio E; Poyart C; Schuepbach RA; Zinkernagel AS
    J Infect Dis; 2017 Jan; 215(2):269-277. PubMed ID: 27247345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human polyspecific immunoglobulin attenuates group A streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model.
    Tarnutzer A; Andreoni F; Keller N; Zürcher C; Norrby-Teglund A; Schüpbach RA; Zinkernagel AS
    Clin Microbiol Infect; 2019 Apr; 25(4):512.e7-512.e13. PubMed ID: 30025835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Phosphatase Activity of the Control of Virulence Sensor (CovS) on Clindamycin-Mediated Streptolysin O Production in Group A
    Chiang-Ni C; Tseng HC; Shi YA; Chiu CH
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31527126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus pyogenes Transcriptome Changes in the Inflammatory Environment of Necrotizing Fasciitis.
    Hirose Y; Yamaguchi M; Okuzaki D; Motooka D; Hamamoto H; Hanada T; Sumitomo T; Nakata M; Kawabata S
    Appl Environ Microbiol; 2019 Nov; 85(21):. PubMed ID: 31471300
    [No Abstract]   [Full Text] [Related]  

  • 5. Highly virulent M1 Streptococcus pyogenes isolates resistant to clindamycin.
    Plainvert C; Martin C; Loubinoux J; Touak G; Dmytruk N; Collobert G; Fouet A; Ploy MC; Poyart C
    Med Mal Infect; 2015; 45(11-12):470-4. PubMed ID: 26602794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clindamycin-resistant Streptococcus pyogenes: report of a case.
    Walsh SR; Ferraro MJ; Durand ML
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):223-5. PubMed ID: 15246514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clindamycin-induced CovS-mediated regulation of the production of virulent exoproteins streptolysin O, NAD glycohydrolase, and streptokinase in Streptococcus pyogenes.
    Minami M; Kamimura T; Isaka M; Tatsuno I; Ohta M; Hasegawa T
    Antimicrob Agents Chemother; 2010 Jan; 54(1):98-102. PubMed ID: 19805566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periorbital necrotizing fasciitis in a previously healthy male.
    Brissette A; Davidson J; Le Saux N; McGraw R; Kratky V; Jinapriya D
    Can J Ophthalmol; 2014 Dec; 49(6):e138-9. PubMed ID: 25433747
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.
    Zimbelman J; Palmer A; Todd J
    Pediatr Infect Dis J; 1999 Dec; 18(12):1096-100. PubMed ID: 10608632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CovRS Two-Component Regulatory System with NADase Induction by Clindamycin Treatment in Streptococcus pyogenes.
    Tatsuno I; Isaka M; Hasegawa T
    Jpn J Infect Dis; 2024 Sep; 77(5):247-252. PubMed ID: 38556301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway.
    Bruun T; Kittang BR; de Hoog BJ; Aardal S; Flaatten HK; Langeland N; Mylvaganam H; Vindenes HA; Skrede S
    Clin Microbiol Infect; 2013 Dec; 19(12):E545-50. PubMed ID: 23795951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of benefit of intravenous immune globulin in a murine model of group A streptococcal necrotizing fasciitis.
    Patel R; Rouse MS; Florez MV; Piper KE; Cockerill FR; Wilson WR; Steckelberg JM
    J Infect Dis; 2000 Jan; 181(1):230-4. PubMed ID: 10608771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.
    Stevens DL
    Emerg Infect Dis; 1995; 1(3):69-78. PubMed ID: 8903167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathogenesis of necrotizing fasciitis.
    Olsen RJ; Musser JM
    Annu Rev Pathol; 2010; 5():1-31. PubMed ID: 19737105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating group A
    Keller N; Boumasmoud M; Andreoni F; Tarnutzer A; von Matt M; Scheier TC; Epprecht J; Weller D; Gómez-Mejia A; Huemer M; von Reibnitz D; Fontein DBY; Marques-Maggio E; Schuepbach RA; Mairpady-Shambat S; Brugger SD; Zinkernagel AS
    mSphere; 2024 Sep; 9(9):e0063424. PubMed ID: 39189777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Contacts of Patients With Severe Invasive Group A Streptococcal Infection.
    de Almeida Torres RS; dos Santos TZ; Torres RA; Petrini LM; Burger M; Steer AC; Smeesters PR
    J Pediatric Infect Dis Soc; 2016 Mar; 5(1):47-52. PubMed ID: 26908491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrotizing fasciitis.
    Hohlweg-Majert B
    Ophthalmology; 2007 Jul; 114(7):1422. PubMed ID: 17613345
    [No Abstract]   [Full Text] [Related]  

  • 18. Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate.
    Cortés-Penfield N; Ryder JH
    Clin Infect Dis; 2023 Jan; 76(2):346-350. PubMed ID: 36056891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on Fox et al's presentation of two invasive group A streptococcal (GAS) infections.
    Mulla ZD
    J Emerg Med; 2003 May; 24(4):473-4. PubMed ID: 12745058
    [No Abstract]   [Full Text] [Related]  

  • 20. [Toxic shock-like syndrome caused by streptococci].
    van Dissel JT; Kullberg BJ; van der Meer JW
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1452-5. PubMed ID: 10443259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.